Inogi R1 Konċentratur tal-Ossiġnu minn Xiao Xu and Qi Yanbin

Id-disinn Inogi R1 Konċentratur tal-Ossiġnu minn Xiao Xu and Qi Yanbin huwa rebbieħ stmat ħafna tal-prestiġjuż 2023 Premju A' Design Award tal-Fidda fil-Kategorija tal-Kompetizzjoni ta' Disinn ta' Apparati u Tagħmir Mediku.

FiddaProdott Mediku· 2023

Inogi R1 Konċentratur tal-Ossiġnu

minn Xiao Xu and Qi Yanbin

Klijent: Nanjing Yinuoji Medical Technology Co., Ltd.

Rebbieħ tal-Premju A' Design Award tal-Fidda fil-Kategorija ta' Prodott Mediku

145,264

Rebbieħ ta' Premju Ivverifikat

Ivverifika l-Istatus tal-Premju għal #149906

Ara fuq A' Design Award Stqarrija għall-Istampa Badge tal-Premju

Kuluri

Id-Disinn

Dwar Inogi R1 Konċentratur tal-Ossiġnu

Inogi R1 huwa konċentratur tal-ossiġnu miniaturizzat għall-użu mediku. L-apparat jipprovdi rata ta' fluss b'polz sa 6 litri fil-minuta. Inogi R1 jissepara l-ossiġnu mill-arja permezz ta' passatur molekulari, għalhekk ma hemm bżonn ta' ebda addittivi, u jilħaq konċentrazzjoni ta' ossiġnu ogħla minn 90 fil-mija. Sistema ta' kontroll żviluppata internament iżżomm it-tħaddim stabbli f'altitudnijiet sa 6000 metru u f'temperaturi sa minus 30 grad Celsius. Bil-batterija, l-unità tkejjel 17.7 b'7.7 b'19.4 ċentimetri u tiżen 1.8 kilogrammi. Il-passatur molekulari u l-batterija jistgħu jinbidlu f'pass wieħed.

Ir-Rikonoxximent

Dwar il-Premju A' Design Award tal-Fidda

Inogi R1 Konċentratur tal-Ossiġnu huwa rebbieħ tal-Premju A' Design Award tal-Fidda, rikonoxximent prestiġjuż straordinarjament mogħti lil disinji tal-ogħla livell, sbieħ u impressjonanti. Ir-rebbieħa tal-Fidda huma xogħlijiet brillanti ħafna u kreattivi ħafna li juru l-għarfien espert, it-talent u l-aċċuratezza tad-disinjaturi tagħhom. Huwa mistenni li Inogi R1 Konċentratur tal-Ossiġnu ikun xogħol mill-isbaħ, eżemplari, professjonali ħafna u innovattiv bil-fond. Dan id-disinn rebbieħ tal-Fidda huwa invenzjoni notevoli u mammirata li tikkontribwixxi biex jitwessgħu l-fruntieri tal-arti, ix-xjenza, id-disinn u t-teknoloġija. Inogi R1 Konċentratur tal-Ossiġnu huwa ħolqien li ħafna jinvidjawh, li jqajjem ix-xewqat, iġib sentimenti pożittivi u joħloq tgħaġġib u mistagħġib.

Wara d-Disinn

Kit għall-Istampa

Krediti, membri tat-tim u dettalji tekniċi pprovduti mid-disinjatur.

Proprjetajiet Uniċi: INOGI-R1 is the first medical grade miniaturized oxygen concentrator with a pulse flow rate of up to 6 L/min. By integrating all functions of those 20kg concentrators from other brands in a compact size, INOGI-R1 is wildly used clinically. The in-house developed “Micro Pressure Control Analysis Technique” adapts to high pressure and low temperature conditions, which supports stable use even at high altitudes (6000m) or in low temperatures (-30°C). This product has been favored among consumers due to impressive performance and affordability.
Dimensjonijiet u Ippakkjar: With battery cell: 17.7*7.7*19.4cm, 1.8kg
Without battery cell: 17.7*7.7*16cm, 1.3kg
INOGI-R1 is 33% smaller and 23% lighter than similar products.
Tikketti: Oxygen generator, miniaturized oxygen generator, COPD, aerospace materials, in-house innovation, medical device, portable device
Teknoloġija tal-Produzzjoni: Backed by the in-house developed control system and an aerospace material compressor, this instrument only uses air instead of any additive to separate oxygen and nitrogen in the air, and filters out all kinds of impurities through the molecular sieve. It allows an unlimited access to oxygen at a concentration above 90% only depending upon power consumption. It comes with an efficient ARM processor that supports precise detection and fast signal processing. The in-house developed intelligent MAAS system simplifies the operation process and enables physical abnormality early warning and health advice, including breathing sensitivity control, breathing rate in-depth monitoring, and big data health management system.
Sfida tad-Disinn: The release of INOGI-R1 provides a good solution for the common technical problems of China’s medical oxygen machine products, including poor stability over a long time, inefficient working of molecular sieve, high power consumption and short service life of compressor, enhances the independent innovation capacity of China’s medical oxygen generators. At present, this product has been granted 47 patents and property rights, which fills the void of subminiaturized high-altitude ultra-low temperature medical grade portable oxygen supply in China, breaking the monopoly of overseas products.
Riċerka: According to a survey, there are about 100 million patients with Chronic Obstructive Pulmonary Disease (COPD) in China, with the rate of missed diagnosis up to 70%, and most patients are often unaware of their discomfort. In this context, efforts should be made to raise the awareness of COPD and turn the scale of poor treatment. Backed by robust features, INOGI-R1 is believed to relieve the discomfort and pain caused by cardiopulmonary dysfunction.
Ispirazzjoni: The oxygen flow rate of commercially available products is up to 5L/min, which is only suitable for patients with mild illnesses and far from attaining the desired medical effect. These deficiencies motivate us to tailor a miniaturized oxygen concentrator with a pulse flow rate of up to 6L/min for lung disease patients with inaccessible oxygen supply.
Tul tal-Proġett: The project commenced in Nanjing, Jiangsu in September 2018, R&D of the complete unit was done and the revolutionary product INOGI-R1 was released in April 2021, exhibited at the IF and Red Dot in April and September 2022 respectively, and also exhibited at the IDPA Exhibition in Tokyo in November 2022.
Fluss tal-Operazzjoni: In addition to the medical field, the use of INOGI-R1 can be further extended to health care, high altitude exercises, highland travel, protection in exercise, emergency rescue, ect., and it is mainly intended for the elderly, children, pregnant women, sub-healthy white-collar workers and students. In addition, INOGI-R1 works properly at the highest altitude of 6,000m and the lowest temperature of -30℃, which immensely broadens the range of applications and scenarios. In the course of everyday use, 100W super charger is enough to keep the unit working for long hours without battery, reducing the environmental impact of battery. This instrument is continuously powered with working hours up to 6 hours after 2-hour fast charge, which can be used even in long hours of traveling. The molecular sieve and the battery can be installed and replaced with one-click operation.
Membri tat-Tim: Xu Xiao、Qi Yanbin